K.-A. Kreuzer
- Hematology top 5%
- Genetics top 10%
- Molecular Biology
- Cancer Research
- Rheumatology
- Co-authors
- Christiane EderTamara AlpermannAnnette FasanVera GrossmannSusanne SchnittgerNorbert SchmitzWolfgang KernTorsten Haferlach
- Topics
- Acute Myeloid Leukemia Research (2 papers)Chronic Lymphocytic Leukemia Research (2 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers)
- Cited by
- HematologyGeneticsCancer Research
- Journals
- LeukemiaCurrent Cancer Drug TargetsTumorDiagnostik & Therapie
- Partner nations
- GermanyUnited Kingdom
In The Last Decade
K.-A. Kreuzer
3 papers receiving 207 citations
Peers
Comparison fields: 5 of 25
- Hematology 162
- Genetics 103
- Molecular Biology 90
- Cancer Research 38
- Rheumatology 27
Countries citing papers authored by K.-A. Kreuzer
This map shows the geographic impact of K.-A. Kreuzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.-A. Kreuzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.-A. Kreuzer more than expected).
Fields of papers citing papers by K.-A. Kreuzer
This network shows the impact of papers produced by K.-A. Kreuzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.-A. Kreuzer. The network helps show where K.-A. Kreuzer may publish in the future.
Co-authorship network of co-authors of K.-A. Kreuzer
This figure shows the co-authorship network connecting the top 25 collaborators of K.-A. Kreuzer. A scholar is included among the top collaborators of K.-A. Kreuzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.-A. Kreuzer. K.-A. Kreuzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 32 | |
| 2 | BENDAMUSTINE (B), followed by OBINUTUZUMAB (G, GA101) and VENETOCLAX (A, ABT-199) in patients with chronic lymphocytic leukemia (CLL): CLL2-BAG PHASE-II-TRIAL of the German CLL Study Group (GCLLSG) | 0 |
| 3 | 153 | |
| 4 | 0 | |
| 5 | 25 |
About K.-A. Kreuzer
K.-A. Kreuzer is a scholar working on Genetics, Hematology and Immunology, having authored 5 papers that have together received 210 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (162 citations), Genetics (103 citations) and Cancer Research (38 citations). K.-A. Kreuzer has collaborated with scholars based in Germany and United Kingdom. Frequent co-authors include Christiane Eder, Tamara Alpermann, Annette Fasan, Vera Grossmann, Susanne Schnittger, Norbert Schmitz, Wolfgang Kern, Torsten Haferlach, Christoph Schmid and Claudia Haferlach. Their work appears in journals such as Leukemia, Current Cancer Drug Targets and TumorDiagnostik & Therapie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.